What Is Tevogen Bio Holdings Inc. (TVGN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Tevogen Bio Holdings Inc. at its current price of $4.78. The composite intrinsic value is estimated at $5.20 (+8.8% average return), with 4 models flagging overvaluation risk. Notably, First Chicago sees the most upside at +210.4% (fair value: $14.84), while ML-RIV is the most conservative at -92.9% ($0.34). The spread between these extremes — +303.3% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About TVGN?
7 of 13 models are currently active for TVGN. Of these, 3 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates TVGN's intrinsic value at $1.80, implying -62.3% downside from the current price. See which stocks rank higher →
How Does TVGN Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, TVGN ranks #126 by Quality of Company score. CirclFi's QOC score of 3.2/10 evaluates 32 fundamental signals. A score of 3.2 signals below-average fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Tevogen Bio Holdings Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is TVGN a Value Trap?
CirclFi's Value Trap algorithm assigns TVGN a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Tevogen Bio Holdings Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Tevogen Bio Holdings Inc. is rated at 3.2/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.
The gap between the most bullish and bearish model spans +303.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every TVGN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across TVGN's 7 active models, average confidence is 22%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad